As vaccine makers set their sights on boosters, new studies unveiled on Wednesday from Johnson & Johnson and Pfizer-BioNTech demonstrated that extra shots can dramatically raise antibodies against the coronavirus. The companies said they were submitting the new data to the Food and Drug Administration for evaluation, and Pfizer has formally asked the agency to…
